文献速递乳腺乳腺X线

比较数字乳腺断层合成与数字乳腺X线摄影的乳腺X线特征及筛查结局的随机对照试验

Mammographic features and screening outcome in a randomized controlled trial comparing digital breast tomosynthesis and digital mammography.
PubMed 文献 · Eur J Radiol · 2021-05-05

在挪威卑尔根开展的随机对照试验纳入28749名女性,其中1015名因乳腺X线发现被召回。比较数字乳腺断层合成(DBT)与数字乳腺X线摄影(DM)筛查后召回者的乳腺X线特征分布,并分析特征与筛查最终结局(包括肿瘤免疫组化亚型)的关联。DBT筛查后乳腺癌最常见特征为毛刺状肿块,DM则为钙化。

要点

  • DBT筛查后召回者中不对称最常见(24.3%),DM也为不对称(38.9%)。
  • DBT筛查后乳腺癌最常见特征为毛刺状肿块(36.8%),DM为钙化(23.0%)。
  • DBT筛查后因边缘模糊肿块召回且良性结局的比例为0.13%,DM为0.28%。

核心结论

  • DBT筛查女性中乳腺癌主导特征为毛刺状肿块,DM筛查女性中最常见特征为钙化;需进一步研究探索尤其在DBT上可见的乳腺X线特征的临床相关性。

研究设计与样本

  • 在挪威卑尔根开展的随机对照试验,纳入28749名女性,其中1015名因乳腺X线发现被召回;乳腺X线特征按改良BI-RADS量表分类,分布比较采用95%置信区间。

关键影像表现/征象

  • 所有召回者中最常见特征为不对称:DBT组24.3%(108/444),DM组38.9%(222/571)。
  • DBT筛查后乳腺癌最常见特征为毛刺状肿块(36.8%,35/95,95%CI:27.2-47.4)。
  • DM筛查后乳腺癌最常见特征为钙化(23.0%,20/87,95%CI:14.6-33.2)。

诊断标准与关键数值

  • DBT筛查女性中因边缘模糊肿块召回后良性结局比例为0.13%(95%CI:0.08-0.21),DM为0.28%(95%CI:0.20-0.38)。
  • DBT筛查女性中因不对称召回的比例为0.70%(95%CI:0.57-0.85),DM为1.46%(95%CI:1.27-1.67)。
  • DBT筛查女性中因遮蔽性肿块召回的比例为0.24%(95%CI:0.16-0.33),DM为0.54%(95%CI:0.43-0.68)。
  • DBT和DM筛查后诊断的非管腔A样癌中,毛刺状肿块均为最常见特征。

局限性

  • 原文结论指出需进一步研究探索尤其在DBT上可见的乳腺X线特征的临床相关性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To compare the distribution of mammographic features among women recalled for further assessment after screening with digital breast tomosynthesis (DBT) versus digital mammography (DM), and to assess associations between features and final outcome of the screening, including immunohistochemical subtypes of the tumour.

METHODS: This randomized controlled trial was performed in Bergen, Norway, and included 28,749 women, of which 1015 were recalled due to mammographic findings. Mammographic features were classified according to a modified BI-RADS-scale. The distribution were compared using 95 % confidence intervals (CI).

RESULTS: Asymmetry was the most common feature of all recalls, 24.3 % (108/444) for DBT and 38.9 % (222/571) for DM. Spiculated mass was most common for breast cancer after screening with DBT (36.8 %, 35/95, 95 %CI: 27.2-47.4) while calcifications (23.0 %, 20/87, 95 %CI: 14.6-33.2) was the most frequent after DM. Among women screened with DBT, 0.13 % (95 %CI: 0.08-0.21) had benign outcome after recall due to indistinct mass while the percentage was 0.28 % (95 %CI: 0.20-0.38) for DM. The distributions were 0.70 % (95 %CI: 0.57-0.85) versus 1.46 % (95 %CI: 1.27-1.67) for asymmetry and 0.24 % (95 %CI: 0.16-0.33) versus 0.54 % (95 %CI: 0.43-0.68) for obscured mass, among women screened with DBT versus DM, respectively. Spiculated mass was the most common feature among women diagnosed with non-luminal A-like cancer after DBT and after DM.

CONCLUSIONS: Spiculated mass was the dominant feature for breast cancer among women screened with DBT while calcifications was the most frequent feature for DM. Further studies exploring the clinical relevance of mammographic features visible particularly on DBT are warranted.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Aase HS, Danielsen AS, Hoff SR, et al. Mammographic features and screening outcome in a randomized controlled trial comparing digital breast tomosynthesis and digital mammography. Eur J Radiol. 2021. PMID: 34053786. doi:10.1016/j.ejrad.2021.109753

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。